PPI Discontinuation Decreases Risks for Gastric, Esophageal Cancer

Discontinuation of long-term proton pump inhibitor (PPI) therapy may decrease the risk for gastric and esophageal cancer. Among 730,176 patients, PPI discontinuation was tied to a decreased risk for gastric cancer and esophageal cancer across most age categories and both sexes.

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ